Boyce Sarah 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Boyce Sarah（CIK 1629383）在 2 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-09-22）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-22 | Atrium Therapeutics, Inc. (RNA) | 董事 | 卖出 | 126,418 | $1.1M |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | President and CEO | 卖出 | 474,861 | $0 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | President and CEO | 卖出 | 6,394 | $463,245 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | President and CEO | 卖出 | 7,993 | $579,093 |
| 2026-01-09 | Avidity Biosciences, Inc. (RNA) | President and CEO | 卖出 | 8,576 | $619,444 |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | President and CEO | 买入 | 31,000 | $0 |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | President and CEO | 卖出 | 15,742 | $1.1M |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | President and CEO | 卖出 | 29,159 | $0 |
| 2025-09-05 | Avidity Biosciences, Inc. (RNA) | President and CEO | 买入 | 50,000 | $62,000 |
| 2025-09-05 | Avidity Biosciences, Inc. (RNA) | President and CEO | 卖出 | 50,000 | $2.5M |
| 2025-08-29 | Avidity Biosciences, Inc. (RNA) | President and CEO | 买入 | 25,000 | $31,000 |
| 2025-08-29 | Avidity Biosciences, Inc. (RNA) | President and CEO | 卖出 | 25,000 | $1.2M |
来源：SEC Form 4 申报文件 · 截至 2026-09-22